Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Transient renal enlargement in pediatric hematopoietic cell transplant recipients.

Chapman T, Bodmer N, Benkeser DC, Hingorani SR, Parisi MT.

Pediatr Transplant. 2014 May;18(3):288-93. doi: 10.1111/petr.12225. Epub 2014 Jan 20.

PMID:
24438462
2.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.

Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. doi: 10.1016/j.bbmt.2015.04.004. Epub 2015 Apr 7.

3.

Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.

Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre CF, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1819-27. doi: 10.1016/j.bbmt.2014.07.021. Epub 2014 Jul 23.

4.

Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1289-94. doi: 10.1002/pbc.22263.

PMID:
19731318
6.

Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.

Nakamae H, Kirby KA, Sandmaier BM, Norasetthada L, Maloney DG, Maris MB, Davis C, Corey L, Storb R, Boeckh M.

Biol Blood Marrow Transplant. 2009 Jun;15(6):694-703. doi: 10.1016/j.bbmt.2009.02.009. Epub 2009 Apr 16.

7.

Costs of pediatric allogeneic hematopoietic-cell transplantation.

Majhail NS, Mothukuri JM, Macmillan ML, Verneris MR, Orchard PJ, Wagner JE, Weisdorf DJ.

Pediatr Blood Cancer. 2010 Jan;54(1):138-43. doi: 10.1002/pbc.22250.

8.

Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation.

Shulman DS, London WB, Guo D, Duncan CN, Lehmann LE.

Biol Blood Marrow Transplant. 2015 May;21(5):913-9. doi: 10.1016/j.bbmt.2015.01.027. Epub 2015 Feb 7.

9.

Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database.

Majhail NS, Mau LW, Denzen EM, Arneson TJ.

Bone Marrow Transplant. 2013 Feb;48(2):294-300. doi: 10.1038/bmt.2012.133. Epub 2012 Jul 9.

10.

Pericardial effusion after pediatric hematopoietic cell transplant.

Aldoss O, Gruenstein DH, Bass JL, Steinberger J, Zhang Y, Defor TE, Tolar J, Verneris MR, Orchard PJ.

Pediatr Transplant. 2013 May;17(3):294-9. doi: 10.1111/petr.12062. Epub 2013 Mar 7.

PMID:
23464863
11.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1776-84. doi: 10.1016/j.bbmt.2012.06.018. Epub 2012 Aug 1.

12.

Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.

Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS.

Biol Blood Marrow Transplant. 2008 Jun;14(6):658-63. doi: 10.1016/j.bbmt.2008.03.008.

13.

Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.

Hoffmeister PA, Storer BE, Macris PC, Carpenter PA, Baker KS.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1081-6. doi: 10.1016/j.bbmt.2013.04.017. Epub 2013 Apr 25.

14.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.

Biol Blood Marrow Transplant. 2008 Jun;14(6):685-92. doi: 10.1016/j.bbmt.2008.03.011.

15.

The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.

Ahmed I, Teruya J, Murray-Krezan C, Krance R.

Pediatr Transplant. 2015 Jun;19(4):391-8. doi: 10.1111/petr.12455. Epub 2015 Mar 23.

16.

Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.

Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2009 May;15(5):564-73. doi: 10.1016/j.bbmt.2009.01.011. Epub 2009 Mar 9.

17.

Urinary elafin and kidney injury in hematopoietic cell transplant recipients.

Hingorani S, Finn LS, Pao E, Lawler R, Schoch G, McDonald GB, Najafian B, Sandmaier B, Gooley T.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):12-20. doi: 10.2215/CJN.01840214. Epub 2014 Nov 11.

18.

Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes.

Saddadi F, Hakemi M, Najafi I, Moghadam K, Ghavamzadeh A, Jahani M, Ganji M, Amini M, Soleimanian T.

Transplant Proc. 2009 Sep;41(7):2895-7. doi: 10.1016/j.transproceed.2009.07.093.

PMID:
19765466
19.

Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant.

Petryk A, Polgreen LE, Zhang L, Hodges JS, Dengel DR, Hoffmeister PA, Steinberger J, Baker KS.

Bone Marrow Transplant. 2014 Feb;49(2):258-63. doi: 10.1038/bmt.2013.156. Epub 2013 Oct 14.

20.

Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.

Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR.

Clin J Am Soc Nephrol. 2009 Feb;4(2):345-53. doi: 10.2215/CJN.02070508. Epub 2009 Jan 14.

Supplemental Content

Support Center